Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis

Summary

The aim of this study is to investigate the efficacy of antibiotic therapy with any antibiotic (IV) and IV (Nebcin®) tobramycin for 5 days followed by Solution for nebuliser inhalation (Tobi®) for 9 days and antibiotic cures using 14 days of tobramycin IV. In the case of positive results, the reduction of the duration of IV treatment of tobramycin from 14 days to 5 days would limit the risk of toxicity.

Timeline

Start

2017-06-13

Primary completion

2020-01-16

Completion

2020-01-16

Drugs

Indications